Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B in Optisol-GS for DMEK
NCT04018417Phase 3Withdrawn
- Sponsor
- Cornea Research Foundation of America
- Start
- Jul 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amphotericin b in fungal keratitis (FK), sponsored by Cornea Research Foundation of America. Planned start Jul 2019; status: withdrawn.
02
Drugs
amphotericin b
03
Conditions
fungal keratitis (FK)
Beyond the preview
Go deeper on NCT04018417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04018417.